Ocular Therapeutix Stock Forecast

Stock Price Forecast

The 9 analysts that cover Ocular Therapeutix stock have a consensus rating of "Strong Buy" and an average price target of $22.56, which forecasts a 154.05% increase in the stock price over the next year. The lowest target is $17 and the highest is $31.

Price Target: $22.56 (+154.05%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$22.56	$21	$31
Change	+91.44%	+154.05%	+136.49%	+249.10%

* Price targets were last updated on Dec 9, 2025.

Analyst Ratings

The average analyst rating for Ocular Therapeutix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	4	4	4	4	4
Buy	4	6	6	6	6	6
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $21	Strong Buy	Maintains	$21	+136.49%	Dec 9, 2025
Serge Belanger Needham	Needham	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+125.23%	Dec 8, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $19 → $21	Strong Buy	Maintains	$19 → $21	+136.49%	Dec 8, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $19	Strong Buy	Reiterates	$19	+113.96%	Nov 25, 2025
Daniil Gataulin Chardan Capital	Chardan Capital	Strong Buy Maintains $21	Strong Buy	Maintains	$21	+136.49%	Nov 5, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

57.15M

from 51.95M

10.00%

from 51.95M

Revenue Next Year

115.83M

from 57.15M

102.68%

from 57.15M

EPS This Year

-1.46

from -1.42

EPS Next Year

-1.13

from -1.46

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	43.52M	51.49M	58.44M	63.72M	51.95M	57.15M	115.83M
Revenue Growth	150.08%	18.32%	13.50%	9.03%	-18.47%	10.00%	102.68%
EPS	-0.98	-0.97	-1.02	-1.22	-1.42	-1.46	-1.13
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	66.8M	290.9M
Avg	57.1M	115.8M
Low	51.3M	52.5M

Revenue Growth

Revenue Growth	2026	2027
High	28.5%	408.9%
Avg	10.0%	102.7%
Low	-1.3%	-8.1%

EPS Forecast

EPS	2026	2027
High	-1.28	-0.64
Avg	-1.46	-1.13
Low	-1.72	-1.38

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.